Related Experiment Video
Updated: Jul 10, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
[Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies
A Kok1, F R Zuure, C J Weegink
1GGD Amsterdam, cluster Infectieziekten, afd. Onderzoek, Postbus 2200, 1000 CE Amsterdam.
Insights
Hepatitis C virus (HCV) infection affects 180 million globally, potentially causing liver failure and cancer. New Dutch studies aim to understand HCV prevalence in at-risk populations.
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Context:
- Hepatitis C virus (HCV) infection is a significant global health concern, with an estimated 180 million individuals infected worldwide.
- HCV can lead to severe liver complications, including liver failure and hepatocellular carcinoma.
- Despite improved treatments, data on HCV prevalence in the Netherlands is limited, hindering public health assessments.
Purpose:
- To address the lack of comprehensive data on Hepatitis C virus (HCV) infection prevalence in the Netherlands.
- To identify and inform key at-risk populations for HCV infection, as recommended by the Dutch Health Council.
- To facilitate epidemiological studies for a better understanding of HCV's public health impact in the Netherlands.
Summary:
- The study focuses on Hepatitis C virus (HCV), a blood-borne infection impacting millions globally and potentially causing liver failure and cancer.
- Identified at-risk groups include injecting drug users, haemodialysis patients, haemophiliacs, individuals exposed to blood products before 1992, and those with specific medical procedure histories.
- Several detection and epidemiological projects for HCV were initiated in the Netherlands in 2007 to improve understanding of the disease's scope.
Impact:
- Provides crucial epidemiological insights into Hepatitis C virus (HCV) infection within the Netherlands.
- Enables more accurate estimations of the public health burden posed by Hepatitis C.
- Supports targeted public health interventions and resource allocation for HCV prevention and control.
Abstract:
Hepatitis C is a blood-borne virus infection with an estimated 180 million infected individuals worldwide. Hepatitis C virus (HCV) infection may lead to liver failure and cancer of the liver. In 2004, in view of the improved treatment options, the Dutch Health Council again recommended that the groups at risk of HCV infection should be tracked down and informed, and that epidemiological studies should be conducted. Currently, there are few data on the prevalence of HCV infection in the Netherlands. HCV risk groups are (former) injecting drug users, haemodialysis patients and haemophiliacs, people treated with blood or blood products before 1992, people who have undergone certain invasive or medical procedures with insufficiently sterilised instruments, household contacts and partners of HCV-infected individuals and children born to HCV-infected mothers. Insight into the epidemiology of HCV infection in the Netherlands is necessary so that reliable estimates of the magnitude of hepatitis C as a public health problem can be made. Several projects for the detection of HCV infected individuals and epidemiological studies have started in 2007.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
